Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Inari Medical Inc (NARI)

Inari Medical Inc (NARI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
79.97 +0.04 (+0.05%) 02/18/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 79.97 unch (unch) -
Quote Overview for Tue, Feb 18th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
79.96
Day High
79.99
Open 79.97
Previous Close 79.93 79.93
Volume 2,359,000 2,359,000
Avg Vol 1,327,835 1,327,835
Stochastic %K 92.10% 92.10%
Weighted Alpha +20.82 +20.82
5-Day Change +0.11 (+0.14%) +0.11 (+0.14%)
52-Week Range 36.73 - 79.99 36.73 - 79.99
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,681,763
  • Shares Outstanding, K 58,544
  • Annual Sales, $ 493,630 K
  • Annual Income, $ -1,640 K
  • EBIT $ -55 M
  • EBITDA $ -58 M
  • 60-Month Beta 1.02
  • Price/Sales 8.08
  • Price/Cash Flow 906.95
  • Price/Book 10.77
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.75
  • Most Recent Earnings $-0.13 on 10/28/24
  • Next Earnings Date 02/26/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.01
  • Number of Estimates 6
  • High Estimate 0.04
  • Low Estimate -0.09
  • Prior Year 0.05
  • Growth Rate Est. (year over year) -120.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.40 +0.72%
on 01/23/25
Period Open: 79.55
79.99 -0.02%
on 02/18/25
+0.42 (+0.53%)
since 01/17/25
3-Month
47.25 +69.25%
on 01/06/25
Period Open: 51.32
79.99 -0.02%
on 02/18/25
+28.65 (+55.83%)
since 11/18/24
52-Week
36.73 +117.72%
on 04/22/24
Period Open: 58.44
79.99 -0.02%
on 02/18/25
+21.53 (+36.84%)
since 02/16/24

Most Recent Stories

More News
If You Could Only Hold 3 Investments for Life, Consider These

Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth.

KO : 73.90 (+1.55%)
SYK : 348.12 (+2.51%)
IVV : 529.38 (+2.52%)
PEP : 143.46 (+1.22%)
SPY : 527.25 (+2.60%)
NARI : 79.97 (+0.05%)
Stocks Retreat as Bond Yields Jump

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -1.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.42% and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.79%. March E-mini...

MSTR : 343.03 (+7.95%)
ALK : 44.94 (+2.88%)
AAPL : 199.74 (+3.41%)
DDOG : 91.42 (+2.81%)
RNG : 22.90 (+3.53%)
$IUXX : 18,276.41 (+2.63%)
NARI : 79.97 (+0.05%)
THC : 114.68 (+3.87%)
ZNM25 : 110-315 (+0.17%)
MSFT : 366.82 (+2.14%)
TSLA : 237.97 (+4.60%)
ESM25 : 5,385.75 (+1.34%)
Stocks Turn Lower as Bond Yields Rise on Strong US Economic Reports

The S&P 500 Index ($SPX ) (SPY ) today is down -0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.93%. March E-mini S&P futures (ESH25...

MSTR : 343.03 (+7.95%)
DDOG : 91.42 (+2.81%)
RNG : 22.90 (+3.53%)
TXN : 146.76 (+0.79%)
RGLD : 181.35 (-2.46%)
$IUXX : 18,276.41 (+2.63%)
NARI : 79.97 (+0.05%)
ZNM25 : 110-315 (+0.17%)
TSLA : 237.97 (+4.60%)
ESM25 : 5,385.75 (+1.34%)
$DOWI : 39,186.98 (+2.66%)
^BTCUSD : 93,138.27 (+2.19%)
Stocks Fall as Treasury Yields Hit 8-Month Highs

The S&P 500 Index ($SPX ) (SPY ) today is down -0.79%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.45%. March E-mini S&P futures...

RNG : 22.90 (+3.53%)
TXN : 146.76 (+0.79%)
RGLD : 181.35 (-2.46%)
$IUXX : 18,276.41 (+2.63%)
NARI : 79.97 (+0.05%)
RJF : 134.77 (+3.00%)
ZNM25 : 110-315 (+0.17%)
ESM25 : 5,385.75 (+1.34%)
QCOM : 138.74 (+1.91%)
$DOWI : 39,186.98 (+2.66%)
SPY : 527.25 (+2.60%)
DIA : 391.87 (+2.69%)
Stock Index Futures Steady With Focus on U.S. JOLTs Report and Fed Speak

March S&P 500 E-Mini futures (ESH25) are up +0.09%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors geared up for the latest reading on U.S. job openings while also...

MSTR : 343.03 (+7.95%)
NVDA : 98.89 (+2.04%)
SNOW : 140.23 (+2.36%)
MU : 70.21 (+5.20%)
ENVX : 6.16 (+0.33%)
SW.FP : 55.000 (-0.45%)
ESH25 : 5,617.80s (-0.79%)
NARI : 79.97 (+0.05%)
TSLA : 237.97 (+4.60%)
VOLVB.S.DX : 250.000 (-0.87%)
NQH25 : 19,450.81s (-1.16%)
CVNA : 211.95 (+8.23%)
Inari Medical to Present at the J.P. Morgan Healthcare Conference

NARI : 79.97 (+0.05%)
Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Inari Medical, Inc. NARI is well poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency...

AXGN : 15.43 (+1.65%)
ARAY : 1.5200 (+4.83%)
MASI : 152.07 (+1.90%)
NARI : 79.97 (+0.05%)
Inari Medical Announces Joint Venture with 6 Dimensions Capital and VFLO Medical to Expand Access in Greater China

Inari Medical announces a joint venture with 6 Dimensions Capital and VFLO Medical to enhance healthcare access in Greater China.Quiver AI SummaryInari Medical, Inc. has announced a joint venture with...

NARI : 79.97 (+0.05%)
Inari Medical Receives National Reimbursement Approval for ClotTriever Thrombectomy System in Japan

Inari Medical received Japanese reimbursement approval for ClotTriever, enhancing DVT treatment options through a new functional category.Quiver AI SummaryInari Medical, Inc. announced that it received...

NARI : 79.97 (+0.05%)
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.

NARI : 79.97 (+0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its...

See More

Key Turning Points

3rd Resistance Point 80.02
2nd Resistance Point 80.00
1st Resistance Point 79.99
Last Price 79.97
1st Support Level 79.96
2nd Support Level 79.94
3rd Support Level 79.93

See More

52-Week High 79.99
Last Price 79.97
Fibonacci 61.8% 63.46
Fibonacci 50% 58.36
Fibonacci 38.2% 53.26
52-Week Low 36.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro